Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes

International Journal of Clinical Practice

Volumn 59, Issue 3, 2005, Pages 281-286

  Baos, V ^a   Ester, F ^b   Castellanos, A ^c   Nocea, G ^d   Caloto, M T ^d   Gerth, William C ^e   Alonso, Rafael ^f   Antón, Javier ^f   Aragón, Belén ^g   Arnés, Francisco ^h   Arranz, Alberto J ^f   Baos, Vicente ⁱ   Bertral, Carmen ^j   Caloto, Ma Teresa ^d   Castellanos, Antonio ^c   Cuevas, Ma Ángeles ^k   del Río, Francisco J ^f   Espigares, Manuel ^l   Ester, Francisco ^m   García, Ma Soledad ^g   Gasull, Vicente ⁿ   Martín, Antonio ^o   Martínez, Enrique ^p   Mezquita, Luis ^q   Nieto, Montserrat ^r   Nocea, Gonzalo ^d   Prieto, Miguel Á ^s   Revilla, Enrique ^t   Rius, Paloma ^r   Serrano, Adalberto ^f   Torrecilla, Miguel ^u   Torres, Milko ^v   Uribe Etxebarría, Lourdes ^f   more..

^a Centro de Salud Collado Villalba   (Spain)

^b Centro Atencion Primaria El Morell   (Spain)

^c Distrito Sanitario Sevilla Norte del Servicio Andaluz de Salud   (Spain)

^d MSD   (Spain)

^e MERCK RESEARCH LABORATORIES   (United States)

^f CS Repélega   (Spain)

^g Chiltern International   (Spain)

^h CS San Javier   (Spain)

ⁱ CS Collado Villalba   (Spain)

^j CAP Cardona   (Spain)

^k Las Águilas Health Centre   (Spain)

^l EAP La Paz   (Spain)

^m CAP El Morell   (Spain)

ⁿ CS Aldaya   (Spain)

^o CS Miraflores   (Spain)

^p CS Muñoz   (Spain)

^q Centro de Salud Gran Capitán   (Spain)

^r CS Ventilla   (Spain)

^s CS Vallobín Concinos   (Spain)

^t CS El Greco   (Spain)

^u Centro de Salud de San Juan   (Spain)

^v CS Buenos Aires   (Spain)

more..

Author keywords

Disability diary; Migraine; Treatment outcomes

Indexed keywords

ANALGESIC AGENT; ERGOT DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; RIZATRIPTAN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISABILITY; DOCTOR PATIENT RELATION; DRUG DOSE REGIMEN; DRUG RESPONSE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; MEDICAL RECORD; MIGRAINE; OPEN STUDY; PAIN ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; SEX RATIO; SPAIN; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; COMMUNICATION; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 20044381267     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2005.00469.x     Document Type: Article

References (22)

1. Lipton RB, Stewart WF, Diamond S et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001; 41: 646-57.
2. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. Headache 2003; 43: 19-26.
3. Laínez JM, Vioque J, Hernández-Aguado I, Titus F. Prevalence of migraine in Spain. An assessment of the questionnaire's validity by clinical interview. In: Olesen J, ed. Frontiers in Headache Research. Headache Classification and Epidemiology. New York, USA: Raven Press, 1994: 221-5.
4. Lipton RB, Scher AI, Kolodner K et al. Migraine in the United States: epidemiology and patterns of health care use. Neurology 2002; 58: 885-94.
5. Krobot KJ, Schroder-Bernhardi D, Pfaffenrath V. Migraine consultation patterns in primary care. Results from the PCAOM study 1994-96. Cephalalgia 1999; 19: 831-40.
6. Lipton RB, Diamond S, Reed M et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001; 41: 638-45.
7. Lipton RB, Scher AI, Steiner TJ et al. Patterns of health care utilization for migraine in England and in the United States. Neurology 2003; 60: 441-8.
8. Silberstein SD, for the US Headache Consortium. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55: 754-62.
9. Dowson AJ, Lipscombe S, Sender J et al. New guidelines for the management of migraine in primary care. Curr Med Res Opin 2002; 18: 414-39.
10. Holmes WF, MacGregor EA, Sawyer JP, Lipton RB. Information about migraine disability influences physicians' perceptions of illness severity and treatment needs. Headache 2001; 41: 343-50.
11. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 2001; 56 (6 Suppl. 1): S20-S28.
12. Lipton RB, Stewart WF, Stone AM et al. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: a randomized trial. JAMA 2000; 284: 2599-605.
13. Brandes JL. Global trends in migraine care: results from the MAZE survey. CNS Drugs 2002; 16 (Suppl. 1): 13-8.
14. Baos V, Serrano A, Torrecilla M et al. Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting. Int J Clin Pract 2003; 57 761-8.
15. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl. 7): 1-96.
16. Davies GM, Santanello N, Gerth W et al. Validation of a migraine work and productivity loss questionnaire for use in migraine studies. Cephalalgia 1999; 19: 497-502.
17. Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD. Validation of a new quality of life questionnaire for acute migraine headache. Headache 1995; 35: 330-7.
18. Hu XH, O'Donnell F, Kunkel RS et al. Survey of migraineurs referred to headache specialists: care, satisfaction, and outcomes. Neurology 2000; 55: 141-3.
19. Block GA, Goldstein J, Polis A et al. Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Headache 1998; 38: 764-71.
20. Solomon S, Frishberg B, Hu XH et al. Migraine treatment outcomes with rizatriptan in triptan-naïve patients: a naturalistic study. Clin Ther 2001; 23: 886-900.
21. Jamieson D, Cutrer FM, Goldstein J et al. Real-world experiences in migraine therapy with rizatriptan. Headache 2003; 43: 223-30.
22. Cady R, Crawford G, Ahrens S et al. Long-term efficacy and tolerability of rizatriptan wafers in migraine. Med Gen Med 2001; 3 (3): 1.